Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 44.0B | 48.9B | 42.2B | 43.6B |
Cost of revenue | 25.2B | 28.1B | 24.3B | 24.6B |
Gross profit | 18.8B | 20.8B | 17.9B | 19.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 149M | 2.0B | 927M | 2.0B |
Non operating interest income | ||||
Income | 57M | 53M | 53M | 58M |
Expense | 0 | 0 | 0 | 0 |
Other income expense | — | — | — | — |
Pretax income | 215M | 2.6B | 1.5B | 2.6B |
Tax provision | 323M | 582M | 507M | 881M |
Net income | -109M | 2.1B | 977M | 1.7B |
Basic EPS | — | — | — | 34.8 |
Diluted EPS | — | — | — | 34.7 |
Basic average shares | — | — | — | 7.2B |
Diluted average shares | — | — | — | 7.2B |
EBITDA | 1.0B | 2.8B | 1.5B | 2.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -12M | -16M | -7M | -15M |
Preferred stock dividends | 0 | 0 | 0 | 0 |